We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$2.22B
AUM Growth
+$375M
Cap. Flow
+$293M
Cap. Flow %
13.2%
Top 10 Hldgs %
17.55%
Holding
845
New
119
Increased
485
Reduced
177
Closed
64

Top Sells

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$14.9M
2
FTI icon
TechnipFMC
FTI
+$13.5M
3
ARAY icon
Accuray
ARAY
+$10.8M
4
IMMR icon
Immersion
IMMR
+$8.19M
5
XONE
The ExOne Company
XONE
+$4.9M

Sector Composition

Rank Sector Weight
1 Technology 25.66%
2 Industrials 13.74%
3 Healthcare 10.47%
4 Consumer Discretionary 8.12%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYGN icon
101
Myriad Genetics
MYGN
$303M
$3.95M 0.18%
115,121
+7,029
+7% +$237K
XONE
102
DELISTED
The ExOne Company
XONE
$3.92M 0.18%
466,857
-464,814
-50% -$4.9M
GDOT icon
103
Green Dot
GDOT
$748M
$3.9M 0.18%
64,751
-1,201
-2% -$70.4K
MU icon
104
Micron Technology
MU
$1.01T
$3.84M 0.17%
93,335
+7,124
+8% +$307K
ICLR icon
105
Icon
ICLR
$12.1B
$3.83M 0.17%
34,145
-1,118
-3% -$129K
FSD
106
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$3.79M 0.17%
228,783
+24,037
+12% +$399K
TDC icon
107
Teradata
TDC
$3.24B
$3.77M 0.17%
97,921
+6,488
+7% +$232K
TRV icon
108
Travelers Companies
TRV
$78.7B
$3.74M 0.17%
27,576
+1,045
+4% +$138K
DAN icon
109
Dana Inc
DAN
$2.97B
$3.73M 0.17%
116,370
+7,106
+7% +$219K
ALLY icon
110
Ally Financial
ALLY
$13.7B
$3.71M 0.17%
127,127
+9,133
+8% +$242K
OC icon
111
Owens Corning
OC
$11.7B
$3.69M 0.17%
40,143
+2,453
+7% +$207K
GM icon
112
General Motors
GM
$77.5B
$3.68M 0.17%
89,848
+1,160
+1% +$50.3K
CVS icon
113
CVS Health
CVS
$133B
$3.68M 0.17%
50,765
-132
-0.3% -$9.6K
PVH icon
114
PVH
PVH
$4.09B
$3.67M 0.17%
26,744
+1,796
+7% +$235K
MLKN icon
115
MillerKnoll
MLKN
$1.66B
$3.67M 0.16%
91,499
+9,205
+11% +$323K
FHI icon
116
Federated Hermes
FHI
$4.85B
$3.66M 0.16%
101,554
+9,565
+10% +$310K
GPK icon
117
Graphic Packaging
GPK
$3.52B
$3.66M 0.16%
237,079
+25,496
+12% +$384K
TROW icon
118
T. Rowe Price
TROW
$24.7B
$3.65M 0.16%
34,822
+2,998
+9% +$292K
PPC icon
119
Pilgrim's Pride
PPC
$6.42B
$3.62M 0.16%
116,592
+9,799
+9% +$320K
UNFI icon
120
United Natural Foods
UNFI
$2.94B
$3.61M 0.16%
73,324
+4,477
+7% +$196K
IDCC icon
121
InterDigital
IDCC
$8.34B
$3.61M 0.16%
47,435
+7,643
+19% +$571K
DAL icon
122
Delta Air Lines
DAL
$61B
$3.6M 0.16%
64,247
+11,340
+21% +$592K
GL icon
123
Globe Life
GL
$14.3B
$3.6M 0.16%
39,665
+55
+0.1% +$4.72K
NTAP icon
124
NetApp
NTAP
$37.4B
$3.6M 0.16%
65,025
+4,047
+7% +$203K
DVA icon
125
DaVita
DVA
$14.6B
$3.59M 0.16%
49,720
-145
-0.3% -$8.92K

Similar funds

Vident Investment Advisory's Q4 2017 Portfolio in Review

As of Q4 2017, Vident Investment Advisory held 845 positions worth $2.22B, up 20% from $1.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Vident Investment Advisory deployed $293M of net new capital in Q4 2017, opening 119 new positions and adding to 485 existing holdings. Its largest new stake was Novanta: 388,786 shares worth $19.4M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Northrop Grumman, an estimated $14.9M trimmed.

  • Vident Investment Advisory's largest Q4 2017 buy was Novanta: 388,786 shares worth $19.4M.
  • Vident Investment Advisory added most to iRobot in Q4 2017, an estimated $18.1M increase.
  • Vident Investment Advisory's biggest Q4 2017 reduction was Northrop Grumman, cutting an estimated $14.9M.
  • Vident Investment Advisory fully exited TechnipFMC in Q4 2017, selling an estimated $13.5M.
  • Vident Investment Advisory's ten largest holdings make up 18% of its $2.22B portfolio in Q4 2017.
  • Vident Investment Advisory opened 119 new positions and closed 64 in Q4 2017.
  • Vident Investment Advisory's portfolio value rose 20% quarter-over-quarter to $2.22B.

Based on Vident Investment Advisory's 13F filing for Q4 2017, filed 15 Feb 2018.